Influence of Ceacams Expression in Graft-Versus-Host Disease After Allogeneic Transplantation

被引:0
|
作者
Koldehoff, Michael
Dreesen, Janine D. [1 ]
Elmaagacli, Ahmet H.
Beelen, Dietrich W. [2 ]
Singer, Bernhard B. [1 ]
机构
[1] Univ Duisburg Essen, Inst Anat, Essen, Germany
[2] Univ Hosp Essen, Dept Bone Marrow Transplantat, Essen, Germany
关键词
D O I
10.1182/blood.V120.21.4490.4490
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4490
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Oral involvement in chronic graft-versus-host disease after allogeneic bone marrow transplantation
    Nakamura, S
    Hiroki, A
    Shinohara, M
    Gondo, H
    Ohyama, Y
    Mouri, T
    Sasaki, M
    Shirasuna, K
    Harada, M
    Niho, Y
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1996, 82 (05): : 556 - 563
  • [42] Proteomic patterns and graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
    Chiusolo, P.
    Bellesi, S.
    Fanali, C.
    Giammarco, S.
    Sica, S.
    Inzitari, R.
    Iavarone, F.
    Leone, G.
    Castagnola, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S13 - S13
  • [43] Invasive zygomycosis in patients with graft-versus-host disease after allogeneic stem cell transplantation
    Leithauser, M.
    Kahl, C.
    Aepinus, C.
    Prall, F.
    Maruschke, M.
    Riemer, H.
    Wolff, D.
    Jost, K.
    Hilgendorf, I.
    Freund, M.
    Junghanss, C.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (03) : 251 - 257
  • [44] Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
    Nassar, Amr
    Elgohary, Ghada
    Elhassan, Tusneem
    Nurgat, Zubeir
    Mohamed, Said Y.
    Aljurf, Mahmoud
    JOURNAL OF TRANSPLANTATION, 2014, 2014
  • [45] Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Chen, Yi-Bin
    Shah, Nirav N.
    Renteria, Anne S.
    Cutler, Corey
    Jansson, Johan
    Akbari, Mona
    Chen, Chunlin
    Quadri, Syed
    Parfionovas, Andrejus
    Devine, Steven M.
    BLOOD ADVANCES, 2019, 3 (23) : 4136 - 4146
  • [46] Serum catalase to predict graft-versus-host disease after allogeneic stem cell transplantation
    Kircher, B.
    Schumacher, P.
    Clausen, J.
    Auberger, J.
    Nachbaur, D.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S118 - S118
  • [47] A CHRONIC PULMONARY SYNDROME ASSOCIATED WITH GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    SCHWARER, AP
    HUGHES, JMB
    TROTMANDICKENSON, B
    KRAUSZ, T
    GOLDMAN, JM
    TRANSPLANTATION, 1992, 54 (06) : 1002 - 1007
  • [48] Graft-versus-host disease induced by tisagenlecleucel in patients after allogeneic stem cell transplantation
    Gabelli, Maria
    Marks, David I.
    Sharplin, Kirsty
    Lazareva, Arina
    Mullanfiroze, Khushnuma
    Farish, Susan
    Burridge, Saskia
    Velangi, Mark
    Rampling, Dyanne
    Mozayani, Behrang
    Chiesa, Robert
    Lucchini, Giovanna
    Samarasinghe, Sujith
    Bartram, Jack
    Ghorashian, Sara
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (05) : 805 - 811
  • [49] Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation
    P Martin
    R Nash
    J Sanders
    W Leisenring
    C Anasetti
    HJ Deeg
    R Storb
    F Appelbaum
    Bone Marrow Transplantation, 1998, 21 : 273 - 279
  • [50] Proteinuria related to chronic graft-versus-host disease after allogeneic stem cell transplantation
    Carrasco-Yalán, AA
    Murillo-Vizcarra, SA
    Moreno-Larrea, M
    Chumpitaz-Anchiraico, G
    Castillo-Aguirre, J
    Mendoza, S
    Somocurcio-Peralta, J
    Liendo-Liendo, C
    Navarro-Cabrera, JR
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 49 - 49